Cargando…

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells

Detalles Bibliográficos
Autor principal:	Kazi, Julhash U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730979/ https://www.ncbi.nlm.nih.gov/pubmed/33260802 http://dx.doi.org/10.3390/ijms21239006

Ejemplares similares

Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
por: Shah, Kinjal, et al.
Publicado: (2023)

Machine learning in the prediction of cancer therapy
por: Rafique, Raihan, et al.
Publicado: (2021)

The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia
por: Shah, Kinjal, et al.
Publicado: (2021)

Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
por: Shah, Kinjal, et al.
Publicado: (2018)

Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012)

Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
por: Shah, Kinjal, et al.
Publicado: (2022)

T-cell Acute Lymphoblastic Leukemia Cells Display Activation of Different Survival Pathways
por: Moharram, Sausan A., et al.
Publicado: (2017)

Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2023)

Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversity
por: Kabir, Nuzhat N., et al.
Publicado: (2011)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
por: Nasimian, Ahmad, et al.
Publicado: (2023)

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)

T cell receptor (TCR) signaling in health and disease
por: Shah, Kinjal, et al.
Publicado: (2021)

PPARs and Anticancer Therapies
por: Robbins, Michael E. C., et al.
Publicado: (2010)

Pseudo-resistance to anticancer drugs
por: Davoli, Enrico, et al.
Publicado: (2022)

FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
por: Chougule, Rohit A., et al.
Publicado: (2016)

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
por: Bazhin, Alexandr V., et al.
Publicado: (2016)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

Emerging concepts in cancer therapy: Mechanisms of resistance
por: Gupta, Seema, et al.
Publicado: (2022)

SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018)

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
por: Feng, Bing, et al.
Publicado: (2022)

Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance
por: Xuan, Xiuyun, et al.
Publicado: (2021)

Mechanisms of resistance to mitochondria-targeted therapy in pancreatic cancer
por: Boukalova, Stepana, et al.
Publicado: (2021)

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2016)

Stem Cells in Cancer Progression and Therapy
por: Tan, Hua, et al.
Publicado: (2019)

Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells
por: Dahn, Margaret L., et al.
Publicado: (2020)

Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
por: Eckerdt, Frank, et al.
Publicado: (2023)

Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”
por: Sarkadi, Balázs
Publicado: (2023)

Mechanism of resistance to cetuximab therapy in colorectal cancer: Possible role of antibodies to immunoglobulin allotypes
por: Pandey, Janardan P.
Publicado: (2012)

Cancer stem cells, the ultimate targets in cancer therapy
por: Shabbir, Ahmed, et al.
Publicado: (2018)

The Role of Extracellular Vesicles in Mediating Resistance to Anticancer Therapies
por: Maleki, Saeideh, et al.
Publicado: (2021)

Targeting anticancer drug-induced senescence in glioblastoma therapy
por: Tomicic, Maja T., et al.
Publicado: (2018)

Anticancer Natural Compounds: Molecular Mechanisms and Functions. Part I
por: Ratovitski, Edward A.
Publicado: (2017)

Anticancer Natural Compounds: Molecular Mechanisms and Functions  Part II
por: Ratovitski, Edward A.
Publicado: (2017)

The Prognostic Role of Cancer Stem Cells in Breast Tumors
por: Bonito, Maurizio Di, et al.
Publicado: (2013)

Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy
por: Budillon, Alfredo, et al.
Publicado: (2019)

Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer Therapy
por: Sharma, Nidhi, et al.
Publicado: (2023)

Anticancer Inhibitors
por: Ammazzalorso, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7cers3sm0ag381v32v0n12pn5j